stockrowABVC BioPharma, Inc. (ABVC) vs Metagenomi Therapeutics, Inc. (MGX)
- ABVC BioPharma, Inc. ABVC 0.97 0.00%
- Metagenomi Therapeutics, Inc. MGX 0.70 −4.11%
ABVC BioPharma, Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Metagenomi Therapeutics, Inc. are of similar size ($27.6M and $25.9M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against −59.8%. ABVC BioPharma, Inc. has the higher net margin (0.00% vs −689.2%) and the lower return on invested capital (−33.5% vs 0.00%). Across the 16 metrics below, ABVC BioPharma, Inc. leads on 9 and Metagenomi Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | ABVC | MGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 100.00% | 68.51% |
| Operating margin | 0.00% | (741.58%) | 0.00% |
| Net margin | 0.00% | (689.20%) | 0.00% |
| Free cash flow margin | 0.00% | (632.67%) | 0.00% |
| Return on equity | (65.32%) | (60.61%) | (51.96%) |
| Return on assets | (39.88%) | (41.91%) | (46.06%) |
| Return on invested capital | (33.45%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack